How soon will we have a vaccine to protect us from coronavirus? That’s the question uppermost on the minds of many Americans, especially the elderly and others especially at risk for a severe bout of the disease.
Everyone wants the vaccine yesterday. Maybe that’s why the media cheered in late May and hope soared when Moderna, a 10-yearold biotechnology company based in Cambridge, ...